J Imaging Inform Med. 2025 Jan 23. doi: 10.1007/s10278-025-01390-0. Online ahead of print.

ABSTRACT

While radiation hazards induced by cone-beam computed tomography (CBCT) in image-guided radiotherapy (IGRT) can be reduced by sparse-view sampling, the image quality is inevitably degraded. We propose a deep learning-based multi-view projection synthesis (DLMPS) approach to improve the quality of sparse-view low-dose CBCT images. In the proposed DLMPS approach, linear interpolation was first applied to sparse-view projections and the projections were rearranged into sinograms; these sinograms were processed with a sinogram restoration model and then rearranged back into projections. The sinogram restoration model was modified from the 2D U-Net by incorporating dynamic convolutional layers and residual learning techniques. The DLMPS approach was trained, validated, and tested on CBCT data from 163, 30, and 30 real patients respectively. Sparse-view projection datasets with 1/4 and 1/8 of the original sampling rate were simulated, and the corresponding full-view projection datasets were restored via the DLMPS approach. Tomographic images were reconstructed using the Feldkamp-Davis-Kress algorithm. Quantitative metrics including root-mean-square error (RMSE), peak signal-to-noise ratio (PSNR), structural similarity (SSIM), and feature similarity (FSIM) were calculated in both the projection and image domains to evaluate the performance of the DLMPS approach. The DLMPS approach was compared with 11 state-of-the-art (SOTA) models, including CNN and Transformer architectures. For 1/4 sparse-view reconstruction task, the proposed DLMPS approach achieved averaged RMSE, PSNR, SSIM, and FSIM values of 0.0271, 45.93 dB, 0.9817, and 0.9587 in the projection domain, and 0.000885, 37.63 dB, 0.9074, and 0.9885 in the image domain, respectively. For 1/8 sparse-view reconstruction task, the DLMPS approach achieved averaged RMSE, PSNR, SSIM, and FSIM values of 0.0304, 44.85 dB, 0.9785, and 0.9524 in the projection domain, and 0.001057, 36.05 dB, 0.8786, and 0.9774 in the image domain, respectively. The DLMPS approach outperformed all the 11 SOTA models in both the projection and image domains for 1/4 and 1/8 sparse-view reconstruction tasks. The proposed DLMPS approach effectively improves the quality of sparse-view CBCT images in IGRT by accurately synthesizing missing projections, exhibiting potential in substantially reducing imaging dose to patients with minimal loss of image quality.

PMID:39849201 | DOI:10.1007/s10278-025-01390-0

Nat Methods. 2025 Jan 23. doi: 10.1038/s41592-024-02503-3. Online ahead of print.

ABSTRACT

Spatially resolved transcriptomics technologies provide high-throughput measurements of gene expression in a tissue slice, but the sparsity of these data complicates analysis of spatial gene expression patterns. We address this issue by deriving a topographic map of a tissue slice-analogous to a map of elevation in a landscape-using a quantity called the isodepth. Contours of constant isodepths enclose domains with distinct cell type composition, while gradients of the isodepth indicate spatial directions of maximum change in expression. We develop GASTON (gradient analysis of spatial transcriptomics organization with neural networks), an unsupervised and interpretable deep learning algorithm that simultaneously learns the isodepth, spatial gradients and piecewise linear expression functions that model both continuous gradients and discontinuous variation in gene expression. We show that GASTON accurately identifies spatial domains and marker genes across several tissues, gradients of neuronal differentiation and firing in the brain, and gradients of metabolism and immune activity in the tumor microenvironment.

PMID:39849132 | DOI:10.1038/s41592-024-02503-3

Sci Rep. 2025 Jan 23;15(1):2961. doi: 10.1038/s41598-025-87309-9.

ABSTRACT

Feature matching in computer vision is crucial but challenging in weakly textured scenes due to the lack of pattern repetition. We introduce the SwinMatcher feature matching method, aimed at addressing the issues of low matching quantity and poor matching precision in weakly textured scenes. Given the inherently significant local characteristics of image features, we employ a local self-attention mechanism to learn from weakly textured areas, maximally preserving the features of weak textures. To address the issue of incorrect matches in scenes with repetitive patterns, we use a cross-attention and positional encoding mechanism to learn the correct matches of repetitive patterns in two scenes, achieving higher matching precision. We also introduce a matching optimization algorithm that calculates the spatial expected coordinates of local two-dimensional heat maps of correspondences to obtain the final sub-pixel level matches. Experiments indicate that, under identical training conditions, the SwinMatcher outperforms other standard methods in pose estimation, homography estimation, and visual localization. It exhibits strong robustness and superior matching in weakly textured areas, offering a new research direction for feature matching in weakly textured images.

PMID:39849068 | DOI:10.1038/s41598-025-87309-9

Sci Rep. 2025 Jan 23;15(1):3000. doi: 10.1038/s41598-024-77118-x.

ABSTRACT

With the global population surpassing 8 billion, waste production has skyrocketed, leading to increased pollution that adversely affects both terrestrial and marine ecosystems. Public littering, a significant contributor to this pollution, poses severe threats to marine life due to plastic debris, which can inflict substantial ecological harm. Additionally, this pollution jeopardizes human health through contaminated food and water sources. Given the annual global plastic consumption of approximately 475 million tons and the pervasive issue of public littering, addressing this challenge has become critically urgent. The Surveillance and Waste Notification (SAWN) system presents an innovative solution to combat public littering. Leveraging surveillance cameras and advanced computer vision technology, SAWN aims to identify and reduce instances of littering. Our study explores the use of the MoViNet video classification model to detect littering activities by vehicles and pedestrians, alongside the YOLOv8 object detection model to identify individuals responsible through facial recognition and license plate detection. Collecting appropriate data for littering detection presented significant challenges due to its unavailability. Consequently, project members simulated real-life littering scenarios to gather the required data. This dataset was then used to train different models, including LRCN, CNN-RNN, and MoViNets. After extensive testing, MoViNets demonstrated the most promising results. Through a series of experiments, we progressively improved the model's performance, achieving accuracy rates of 93.42% in the first experiment, 95.53% in the second, and ultimately reaching 99.5% in the third experiment. To detect violators' identities, we employed YOLOv8, trained on the KSA vehicle plate dataset, achieving 99.5% accuracy. For face detection, we utilized the Haar Cascade from the OpenCV library, known for its real-time performance. Our findings will be used to further enhance littering behavior detection in future developments.

PMID:39848984 | DOI:10.1038/s41598-024-77118-x

ISA Trans. 2025 Jan 13:S0019-0578(25)00013-8. doi: 10.1016/j.isatra.2025.01.012. Online ahead of print.

ABSTRACT

Existing cross-domain mechanical fault diagnosis methods primarily achieve feature alignment by directly optimizing interdomain and category distances. However, this approach can be computationally expensive in multi-target scenarios or fail due to conflicting objectives, leading to decreased diagnostic performance. To avoid these issues, this paper introduces a novel method called domain feature disentanglement. The key to the proposed method lies in computing domain features and embedding domain similarity into neural networks to assist in extracting cross-domain invariant features. Specifically, the neural network architecture designed based on information theory can disentangle key features from multiple entangled latent variables. It employs the concept of contrastive learning to extract domain-relevant information from each data point and uses the Wasserstein distance to determine the similarity relationships across all domains. By informing the neural network of domain similarity relationships, it learns how to extract cross-domain invariant features through adversarial learning Eight multi-target domain adaptation tasks were set up on two public datasets, and the proposed method achieved an average diagnostic accuracy of 96.82%, surpassing six other advanced domain adaptation methods, demonstrating its superiority.

PMID:39848906 | DOI:10.1016/j.isatra.2025.01.012

Sci Rep. 2025 Jan 23;15(1):3007. doi: 10.1038/s41598-025-87474-x.

ABSTRACT

The traditional Chinese medicine compound preparation known as Jinbei Oral Liquid (JBOL) consists of 12 herbs, including Astragalus membranaceus (Fisch.) Bge, Codonopsis pilosula (Franch.) Nannf, et al. Having been used for over 30 years in the treatment of pulmonary diseases, JBOL was evaluated in this study in order to assess its effect on idiopathic pulmonary fibrosis as well as its safety (ChiCTR2000035351, Chictr.org.cn.09/08/2020). A double-blind, multicenter, randomized, proof-of-concept trial was conducted to assess the efficacy of oral JBOL 40 ml and Corbrin Capsules 1 g compared to a placebo and Corbrin Capsules in patients with idiopathic pulmonary fibrosis (IPF). Over a 26-week period, patients received the active treatment or placebo three times daily, in a 1:1 ratio. This clinical study uses a randomized method, with a cycle of every 4 patients. TCM doctors at or above the deputy director level of the research center conduct TCM dialectics on IPF patients. To assess efficacy, over the duration of the trial, we measured serial changes in a composite indicator encompassing time to first acute exacerbation of IPF (first hospitalization or death due to respiratory cause), total lung capacity (TLC) (mL), predicted forced vital capacity (FVC%), forced vital capacity (FVC) (mL), predicted diffusing capacity of the lungs for carbon monoxide (predicted DLco%), 6-minute walk distance (6MWD), St. George's Respiratory Questionnaire (SGRQ) total score, and arterial oxygen partial pressure (PaO2) from baseline to week 26 versus placebo. A total of 103 patients were screened, and 72 received the study medication. Of these, 68 patients were included in the analysis set, with 34 receiving JBOL and 34 receiving a placebo. After 26 weeks, a statistically significant reduction in total lung capacity (TLC) was observed for the JBOL group, with a change of 136 mL compared to -523 mL for the placebo group (difference 659 mL, 95% CI -1215 to -104 mL, p = 0.02). The study found that the change in FVC% predicted was - 1.48% and - 3.58% for the JBOL and placebo groups, respectively (difference of 2.10%, 95% CI -7.13 to 2.93, p = 0.41). Additionally the differences between the two groups in changes in FVC (mL), DLCO % predicted, PaO2 (mmHg) measures were - 67 mL (95% CI -238 to 104), -7.74% (95% CI -17.26 to 1.79), and - 3.57 mmHg (95% CI -10.02 to 2.87), respectively. Treatment with JBOL compared to placebo resulted in sequential changes in acute exacerbation, with no significant difference in SGRQ scores. It was not found that there was a statistically significant difference between the JBOL and placebo groups in TEAE reporting and serious TEAE reporting. Compared to the placebo group, there was a statistically significant reduction (p < 0.021) in TLC (mL) after 26 weeks for JBOL. The rates of FVC % predicted, FVC, DLCO % predicted, and PaO2 in the group treatment with JBOL were numerically lower than those in the placebo treatment group, although these differences did not reach statistical significance. JBOL exhibited comparable safety to placebo. This study has preliminarily shown the efficacy and safety of JBOL for IPF, but this is an exploratory clinical trial, more patient-involved studies should be needed in the near future.Trial registration: Chictr.org.cn ChiCTR2000035351; the trial was prospective clinical studies registered on August 9, 2020.

PMID:39849152 | DOI:10.1038/s41598-025-87474-x

Thorax. 2025 Jan 22:thorax-2024-222754. doi: 10.1136/thorax-2024-222754. Online ahead of print.

NO ABSTRACT

PMID:39848685 | DOI:10.1136/thorax-2024-222754

Int J Biochem Cell Biol. 2025 Jan 21:106739. doi: 10.1016/j.biocel.2025.106739. Online ahead of print.

ABSTRACT

Lung fibrosis, including idiopathic pulmonary fibrosis (IPF), is a complex and devastating disease characterised by the progressive scarring of lung tissue leading to compromised respiratory function. Aberrantly activated fibroblasts deposit extracellular matrix components into the surrounding lung tissue, impairing lung function and capacity for gas exchange. Both genetic and epigenetic factors have been found to play a role in the pathogenesis of lung fibrosis, with emerging evidence highlighting the interplay between these two regulatory mechanisms. This review provides an overview of the current understanding of the interplay between genetics and epigenetics in lung fibrosis. We discuss the genetic variants associated with susceptibility to lung fibrosis and explore how epigenetic modifications such as DNA methylation, histone modifications, and non-coding RNA expression contribute to disease. Insights from genome-wide association studies (GWAS) and epigenome-wide association studies (EWAS) are integrated to explore the molecular mechanisms underlying lung fibrosis pathogenesis. We also discuss the potential clinical implications of genetics and epigenetics in lung fibrosis, including the development of novel therapeutic targets. Overall, this review highlights the importance of considering both genetic and epigenetic factors in the understanding and management of lung fibrosis.

PMID:39848439 | DOI:10.1016/j.biocel.2025.106739

Sci Rep. 2025 Jan 23;15(1):2948. doi: 10.1038/s41598-025-86854-7.

ABSTRACT

Many cellular patterns exhibit a reaction-diffusion component, suggesting that Turing instability may contribute to pattern formation. However, biological gene-regulatory pathways are more complex than simple Turing activator-inhibitor models and generally do not require fine-tuning of parameters as dictated by the Turing conditions. To address these issues, we employ random matrix theory to analyze the Jacobian matrices of larger networks with robust statistical properties. Our analysis reveals that Turing patterns are more likely to occur by chance than previously thought and that the most robust Turing networks have an optimal size, consisting of only a handful of molecular species, thus significantly increasing their identifiability in biological systems. Broadly speaking, this optimal size emerges from a trade-off between the highest stability in small networks and the greatest instability with diffusion in large networks. Furthermore, we find that with multiple immobile nodes, differential diffusion ceases to be important for Turing patterns. Our findings may inform future synthetic biology approaches and provide insights into bridging the gap to complex developmental pathways.

PMID:39849094 | DOI:10.1038/s41598-025-86854-7

Sci Rep. 2025 Jan 23;15(1):2982. doi: 10.1038/s41598-024-82517-1.

ABSTRACT

Recent research has identified sex-dependent links between risk taking behaviors, approach-avoidance bias and alcohol intake. However, preclinical studies have typically assessed alcohol drinking using a singular dimension of intake (i.e. drinking level), failing to capture the multidimensional pattern of aberrant alcohol-seeking observed in alcohol use disorder. In this study, we sought to further explore individual and sex differences in the relationship between approach-avoidance bias, frontloading (bingeing and onset skew) and multiple addiction-like indices of ethanol seeking that included motivation for ethanol, persistence despite its absence (extinction), and ethanol-taking in the face of mild footshock. We found that female rats displayed more addiction-like phenotypes than males overall, and that frontloading patterns differed by sex, with females outdrinking males in the early part of access sessions (bingeing), but males strongly concentrating their lever pressing for ethanol in that period (onset skew). Multiple regression analyses revealed that bingeing was a strong positive predictor and onset skew a negative predictor of motivational breakpoint. Cued-conflict preference - a measure of approach-avoidance bias towards a mixed-valence conflict cue - was predictive of both extinction and footshock in males, but not females. Our data highlight key sex differences, and the relevance of both frontloading patterns and conflict preference in predicting future addiction-like phenotypes.

PMID:39848982 | DOI:10.1038/s41598-024-82517-1

Free Radic Biol Med. 2025 Jan 21:S0891-5849(25)00052-8. doi: 10.1016/j.freeradbiomed.2025.01.042. Online ahead of print.

ABSTRACT

Cuproptosis, a copper-dependent form of regulated cell death, has been implicated in the progression and treatment of various tumors. The copper ionophores, such as Disulfiram (DSF), an FDA-approved drug previously used to treat alcohol dependence, have been found to induce cuproptosis. However, the limited solubility and effectiveness of the combination of DSF and copper ion restrict its widespread application. In this study, through a random screening of our in-house compound library, we identified a novel cuproptosis inducer, YL21, comprising a naphthoquinone core substituted by two dithiocarbamate groups. The combination of YL21 with copper ion induces cuproptosis by disrupting mitochondrial function and promoting the oligomerization of lipoylated protein DLAT. Further, this combination induces endoplasmic reticulum (ER) stress and oxidative stress, triggering immunogenic cell death (ICD) and subsequently promoting the activation of antitumor immune responses to suppress tumor growth in the mice breast cancer model. Notably, the combination of YL21 and copper ion demonstrated improved solubility and increased antitumor activity compared to the combination of DSF and copper ion. Thus, YL21 functions as a novel cuproptosis inducer and may serve as a promising candidate for antitumor immunotherapy.

PMID:39848344 | DOI:10.1016/j.freeradbiomed.2025.01.042

J Psychiatr Res. 2025 Jan 20;182:329-337. doi: 10.1016/j.jpsychires.2025.01.039. Online ahead of print.

ABSTRACT

Major depressive disorder (MDD) is a highly prevalent and debilitating disorder, yet its pathophysiology has not been fully elucidated. The aim of this study is to identify novel potential proteins and biological processes associated with MDD through a systems biology approach. Original articles involving the measurement of proteins in the blood of patients diagnosed with MDD were selected. Data on the differentially expressed proteins (DEPs) in each article were extracted and imported into R, and the pathfindR package was used to identify the main gene ontology terms involved. Data from the STRING database were combined with the DEPs identified in the original studies to create expanded networks of protein-protein interactions (PPIs). An R script was developed to obtain the five most reliable connections from each DEP and to create the networks, which were visualized through Cytoscape software. Out of 510 articles found, eight that contained all the values necessary for the analysis were selected, including 1112 adult patients with MDD and 864 controls. A total of 240 DEPs were identified, with the most significant gene ontology term being "endoplasmic reticulum lumen" (46 DEPs, p-value = 5.5x10-13). An extended PPI network was obtained, where Anoctamin-8 was the most central protein. Using systems biology contributed to the interpretation of data obtained in proteomic studies on MDD and expanded the findings of these studies. The combined use of these methodologies can provide new insights into the pathophysiology of psychiatric disorders, identifying novel biomarkers to improve diagnostic, prognostic, and treatment strategies in MDD.

PMID:39848100 | DOI:10.1016/j.jpsychires.2025.01.039

Int Immunopharmacol. 2025 Jan 22;148:114090. doi: 10.1016/j.intimp.2025.114090. Online ahead of print.

ABSTRACT

INTRODUCTION: Biomarkers play a crucial role across various fields by providing insights into biological responses to interventions. High-throughput gene expression profiling technologies facilitate the discovery of data-driven biomarkers through extensive datasets. This study focuses on identifying biomarkers in gene expression data related to chemical injuries by mustard gas, covering a spectrum from healthy individuals to severe injuries.

MATERIALS AND METHODS: The study utilized RNA-Seq data comprising 52 expression data samples for 54,583 gene transcripts. These samples were categorized into four classes based on the GOLD classification for chemically injured individuals: Severe (n = 14), Moderate (n = 11), Mild (n = 16), and healthy controls (n = 11). Data preparation involved examining an Excel file created in the R programming environment using MLSeq and devtools packages. Feature selection was performed using Genetic Algorithm and Simulated Annealing, with Random Forest algorithm employed for classification. Ab initio methods ensured computational efficiency and result accuracy, while molecular dynamics simulation acted as a virtual experiment bridging the gap between experimental and theoretical experiences.

RESULTS: A total of 12 models were created, each introducing a list of differentially expressed genes as potential biomarkers. The performance of models varied across group comparisons, with the Genetic Algorithm generally outperforming Simulated Annealing in most cases. For the Severe vs. Moderate group, GA achieved the best performance with an accuracy of 94.38%, recall of 91.64%, and specificity of 97.10%. The results highlight the effectiveness of GA in most group comparisons, while SA performed better in specific cases involving Moderate and Mild groups. These biomarkers were evaluated against the gene expression data to assess their expression changes between different groups of chemically injured individuals. Four genes were selected based on level expression for further investigation: CXCR1, EIF2B2, RAD51, and RXFP2. The expression levels of these genes were analyzed to determine their differential expression between the groups.

CONCLUSION: This study was designed as a computational effort to identify diagnostic biomarkers in basic biological system research. Our findings proposed a list of discriminative biomarkers capable of distinguishing between different groups of chemically injured individuals. The identification of key genes highlights the potential for biomarkers to serve as indicators of chemical injury severity, warranting further investigation to validate their clinical relevance and utility in diagnosis and treatment.

PMID:39847951 | DOI:10.1016/j.intimp.2025.114090

J Invest Dermatol. 2025 Jan 21:S0022-202X(25)00034-X. doi: 10.1016/j.jid.2024.12.025. Online ahead of print.

ABSTRACT

TRIAL DESIGN: This two-part, double-blinded trial assessed the truncated retinoic acid-related orphan receptor γ (RORγt) inhibitor BI 730357 in plaque psoriasis.

METHODS: Part 1: patients were randomized 2:2:2:2:1 to BI 730357 25, 50, 100, 200 mg, or placebo once daily (qd; fasting conditions); non-responders switched to higher doses. Part 2: a separate patient set was randomized 4:4:1 to BI 730357 400 mg qd, 200 mg twice daily, or placebo (fed conditions). Patients from Parts 1 and 2 could enter a long-term extension (LTE) trial. Co-primary endpoints: ≥75% reduction from baseline in Psoriasis Area Severity Index (PASI 75) and static physician's global assessment (sPGA) score 0/1 (clear/almost clear) at week 12.

RESULTS: 274 patients were treated (178 [Part 1]; 96 [Part 2]). Part 1: 12 (30.0%) patients achieved PASI 75 (P=0.0062) and 11 (27.5%) achieved sPGA 0/1 (P=0.0095) with BI 730357 200 mg versus none receiving placebo. Exposure-response plateaued at BI 730357 ≥200 mg qd. Drug-related adverse events occurred in ≤15.8% of patients. Of 165 patients who entered the LTE, 93 (56.4%) achieved PASI 75 during treatment and ≤18.5% experienced a drug-related adverse event.

CONCLUSIONS: BI 730357 was well-tolerated with moderate efficacy versus placebo in plaque reduction.

PMID:39848568 | DOI:10.1016/j.jid.2024.12.025

Curr Res Transl Med. 2025 Jan 17;73(2):103496. doi: 10.1016/j.retram.2025.103496. Online ahead of print.

ABSTRACT

Drug repurposing is a promising strategy for managing cardiovascular disease (CVD) in geriatric populations, offering efficient and cost-effective solutions. CVDs are prevalent across all age groups, with a significant increase in prevalence among geriatric populations. The middle-age period (40-65 years) is critical due to factors like obesity, sedentary lifestyle, and psychosocial stress. In individuals aged 65 and older, the incidence of CVDs is highest due to age-related physiological changes and prolonged exposure to risk factors. In this review we find that certain drugs, such as non-cardiovascular drugs like anakinra, probenecid, N-acetyl cysteine, quercetin, resveratrol, rapamycin, colchicine, bisphosphonates, hydroxychloroquine, SGLT-2i drugs, GLP-1Ras drugs and sildenafil are recommended for drug repurposing to achieve cardiovascular benefits in geriatric patients. However, agents such as canakinumab, methotrexate, ivermectin, erythromycin, capecitabine, carglumic acid, chloroquine, and furosemide are constrained in their therapeutic use and warrant meticulous consideration, rendering them less favorable for this specific application. This review emphasizes the importance of exploring alternative therapeutic strategies to improve outcomes in geriatric populations and suggests drug repurposing as a promising avenue to enhance treatment efficacy.

PMID:39847829 | DOI:10.1016/j.retram.2025.103496

JMIR Res Protoc. 2025 Jan 23;14:e65137. doi: 10.2196/65137.

ABSTRACT

BACKGROUND: Injectable platelet-rich fibrin (i-PRF) has the capacity to release great amounts of several growth factors, as well as to stimulate increased fibroblast migration and the expression of collagen, transforming growth factor β, and platelet-derived growth factor. Consequently, i-PRF can be used as a bioactive agent to promote periodontal tissue regeneration.

OBJECTIVE: We aim to compare and evaluate the effectiveness of i-PRF in periodontal tissue regeneration.

METHODS: We will conduct an electronic search in the following databases: PubMed, Cochrane Library, Google Scholar, Semantic Scholar, Scopus, and Web of Science. Papers will be restricted to those in English and to those that are randomized controlled trials comparing PRF or any other biomaterial with i-PRF for periodontal regeneration during dental treatment. The included papers in this review and the reference lists of pertinent reviews will be manually searched. The selection of studies, data extraction, and assessment will be carried out separately by 2 reviewers using the Risk of Bias 2 tool for the included research.

RESULTS: The success of i-PRF will be evaluated by comparing the mean difference in periodontal regeneration of soft and hard tissues in terms of gingival recession, probing pocket depth, clinical attachment level, bone gain, and gingival width. The combined effect size measurements and the associated 95% CIs will be estimated using a random-effects model. The synthesis or work for this systematic review started in October 2023 and will last until December 2025.

CONCLUSIONS: i-PRF may play a role in dentistry and could enhance soft and hard tissue regeneration.

TRIAL REGISTRATION: PROSPERO CRD42023464250; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=464250.

INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/65137.

PMID:39847766 | DOI:10.2196/65137

Annu Rev Pharmacol Toxicol. 2025 Jan;65(1):111-130. doi: 10.1146/annurev-pharmtox-061724-080718.

ABSTRACT

Pharmacogenetic variation is common and an established driver of response for many drugs. There has been tremendous progress in pharmacogenetics knowledge over the last 30 years and in clinical implementation of that knowledge over the last 15 years. But there have also been many examples where translation has stalled because of the lack of available data sets for discovery or validation research. The recent availability of data from very large cohorts with linked genetic, electronic health record, and other data promises new opportunities to advance pharmacogenetics research. This review presents the stages from pharmacogenetics discovery to widespread clinical adoption using prominent gene-drug pairs that have been implemented into clinical practice as examples. We discuss the opportunities that the All of Us Research Program and other large biorepositories with genomic and linked electronic health record data present in advancing and accelerating the translation of pharmacogenetics into clinical practice.

PMID:39847465 | DOI:10.1146/annurev-pharmtox-061724-080718

Soft comput. 2024;28(Suppl 1):67. doi: 10.1007/s00500-024-09993-5. Epub 2024 Jul 22.

ABSTRACT

[This retracts the article DOI: 10.1007/s00500-020-05275-y.].

PMID:39847670 | PMC:PMC11753128 | DOI:10.1007/s00500-024-09993-5

Soft comput. 2024;28(Suppl 1):295. doi: 10.1007/s00500-024-10107-4. Epub 2024 Aug 27.

ABSTRACT

[This retracts the article DOI: 10.1007/s00500-023-08313-7.].

PMID:39847665 | PMC:PMC11753125 | DOI:10.1007/s00500-024-10107-4

Soft comput. 2024;28(Suppl 1):65. doi: 10.1007/s00500-024-09992-6. Epub 2024 Jul 22.

ABSTRACT

[This retracts the article DOI: 10.1007/s00500-020-05424-3.].

PMID:39847664 | PMC:PMC11753127 | DOI:10.1007/s00500-024-09992-6